Stingeni, L., Ravasio, R., Palladino, C., Di Fino, S., Levi, A., Ronci, G., & Gisondi, P. (2025). Cost per responder of upadacitinib 30 mg and dupilumab 300 mg in patients with moderate-to-severe atopic dermatitis in italy. Global and Regional Health Technology Assessment, 12(1), 70–79. https://doi.org/10.33393/grhta.2025.3458